PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
24-Apr-2024 CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update CureVac
24-Apr-2024 CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with GSK CureVac
24-Apr-2024 CureVac Appoints Thaminda Ramanayake as New Chief Business Officer CureVac
24-Apr-2024 BeiGene Receives European Commission Approval for Tislelizumab as Treatment for Non-Small Cell Lung Cancer BeiGene
24-Apr-2024 Chiesi Group's 2023 Revenue Surpasses €3 Billion Mark, Reflecting 10% Growth Year-on-Year (+12% @CER), Underlining Commitment to Innovative, Sustainable Practices Chiesi Group
24-Apr-2024 TRYP THERAPEUTICS PROVIDES UPDATE ON PLAN OF ARRANGEMENT WITH EXOPHARM LIMITED AND ANNOUNCES VOLUNTARY TRADING HALT Tryp Therapeutics Inc.
24-Apr-2024 Kuros reports Corporate Highlights as of Q1 2024 including increase in direct MagnetOsTM sales Kuros Biosciences AG
24-Apr-2024 Evotec presents fiscal year 2023 results and announces priority reset to focus on profitable growth Evotec SE
23-Apr-2024 Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer Evotec SE
23-Apr-2024 Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer Evotec SE
23-Apr-2024 SYNBIOTIC acquires Ilesol: Enormous competitive advantages through cannabinoid extracts and isolates from own production SynBiotic SE
23-Apr-2024 DEFENCE’S ACCUTOX ANTI-CANCER ARM-002 VACCINE EXHIBITS POTENT ANTIGEN PRESENTATION Defence Therapeutics Inc.
23-Apr-2024 Xlife Sciences AG Publishes 2023 Annual Report Xlife Sciences AG
22-Apr-2024 Viromed Medical AG reaches important milestone – agreement with CORIUS Group for exclusive use of Plasma Care® by Viromed with significant growth potential Viromed Medical AG
22-Apr-2024 Eckert & Ziegler: Q1 with Significant Increase in Sales and Earnings Compared to Previous year. 2024 Annual Forecast Confirmed. Eckert & Ziegler SE
22-Apr-2024 Viromed Medical AG concludes agreement with CORIUS Group for exclusive use of cold plasma therapy with Plasma Care® – Additional earnings contribution of EUR 0.28 to EUR 0.34 per share expected Viromed Medical AG
22-Apr-2024 Formycon invites to the conference call on the results of the financial year 2023 and announces participation in international investor conferences in the 2nd quarter of 2024 Formycon AG
22-Apr-2024 aap closes Q1 2024 with sales growth of 5.6% and positive developments at all operating levels and makes a strong start to Q2 2024 aap Implantate AG
21-Apr-2024 Agenda Announced for Semantic Data 2024: Taxonomy, Ontology, and Knowledge Graphs conference in London Henry Stewart Events
19-Apr-2024 SYNLAB AG: SYNLAB affected by cyber-attack in Italy SYNLAB AG